Management of cancer pain in adult patients: ESMO Clinical Practice Guidelines
Open accessThe DOI matches its Crossref record; 184 of the 184 references it cites were found in a registry or an index.
Abstract
Pain is common in cancer patients, particularly in the advanced stage of disease when the prevalence is estimated to be more than 70% [1], contributing to poor physical and emotional well-being. The most comprehensive systematic review indicates pain prevalence ranging from 33% in patients after curative treatment, to 59% in patients on anticancer treatment and to 64% in patients with metastatic, advanced or terminal disease [2]. Pain has a high prevalence earlier in disease in specific cancer types such as pancreatic (44%) and head and neck cancer (40%) [3].
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



![Figure 2 The assessment of BTcP. BTcP, breakthrough cancer pain. Reprinted with permission from [116].](https://figures.cochat.ai/paper-figures/ca72788a69f549f1926fbf99429f0118/management-of-cancer-pain-in-adult-patients-esmo-clinical-practice-guidelines-figure-2.png)







Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“and the recent ESMO guidelines106 are difficult to follow in those countries where the majority of patients experiencing cancer pain live.”
From 5th ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 5) (2020) · cites this paper as [106]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Global cancer statistics, 2012
Torre, L. A., Bray, F., Siegel, R. L., Ferlay, J., Lortet‐Tieulent, J., & Jemal, A. (2015) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21262 · Cited by 26,850
Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis
Finnerup, N. B., Attal, N., Haroutounian, S., McNicol, E., Baron, R., Dworkin, R. H., Gilron, I., Haanpää, M., Hansson, P., Jensen, T. S., et al. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70251-0 · Cited by 3,980
Treede (2008) · doi:10.1212/01.wnl.0000282763.29778.59 · Cited by 2,746
Opioid Complications and Side Effects
Benyamin, R. (2008) · Pain Physician · doi:10.36076/ppj.2008/11/s105 · Cited by 2,245
Pain and Its Treatment in Outpatients with Metastatic Cancer
Cleeland, C. S., Gonin, R., Hatfield, A. K., Edmonson, J. H., Blum, R. H., Stewart, J. A., & Pandya, K. J. (1994) · New England Journal of Medicine · doi:10.1056/nejm199403033300902 · Cited by 2,019
Fizazi, K., Carducci, M., Smith, M., Damião, R., Brown, J., Karsh, L., Milecki, P., Shore, N., Rader, M., Wang, H., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(10)62344-6 · Cited by 1,971
Prevalence of pain in patients with cancer: a systematic review of the past 40 years
van den Beuken-van Everdingen, M. H. J., de Rijke, J. M., Kessels, A. G., Schouten, H. C., van Kleef, M., & Patijn, J. (2007) · Annals of Oncology · doi:10.1093/annonc/mdm056 · Cited by 1,923
Stopeck, A. T., Lipton, A., Body, J.-J., Steger, G. G., Tonkin, K., de Boer, R. H., Lichinitser, M., Fujiwara, Y., Yardley, D. A., Viniegra, M., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2010.29.7101 · Cited by 1,597
Knaul, F. M., Farmer, P. E., Krakauer, E. L., De Lima, L., Bhadelia, A., Jiang Kwete, X., Arreola-Ornelas, H., Gómez-Dantés, O., Rodriguez, N. M., Alleyne, G. A. O., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(17)32513-8 · Cited by 1,456
Caraceni, A., Hanks, G., Kaasa, S., Bennett, M. I., Brunelli, C., Cherny, N., Dale, O., De Conno, F., Fallon, M., Hanna, M., et al. (2012) · The Lancet Oncology · doi:10.1016/s1470-2045(12)70040-2 · Cited by 1,243
Self-citation
Cited by
Items 401–500 of 954
LeBaron, V. T., Horton, B. J., Adhikari, A., Chapagain, S., Dhakal, M., Gongal, R. N., Kattel, R., Koirala, G., Kutcher, A. M., Hass, B., et al. (2022) · Frontiers in Pain Research · doi:10.3389/fpain.2022.910995 · Cited by 7
Feder, S. L., Canavan, M., Wang, S., Kent, E. E., Kapo, J. M., Presley, C. J., Ross, J. S., & Davidoff, A. J. (2020) · Journal of Palliative Medicine · doi:10.1089/jpm.2020.0193 · Cited by 5
“Opioids have long been a mainstay treatment for patients with cancer experiencing pain.(29,30) Although patients with cardiopulmonary conditions often report pain as frequently and of similar severity to patients with cancer,(31) clinical practice guidelines offer few recommendations for the treatment of pain for thes…”
BackgroundInterventional Oncology: A new pillar for a comprehensive cancer care
Cornélis, F., & Lotz, J. P. (2019) · La Presse Médicale · doi:10.1016/j.lpm.2019.07.017 · Cited by 5
Varadpande, M., Erridge, S., Aggarwal, A., Cowley, I., Evans, L., Clarke, E., McLachlan, K., Coomber, R., Rucker, J., Platt, M. W., et al. (2025) · Journal of Pain & Palliative Care Pharmacotherapy · doi:10.1080/15360288.2025.2457101 · Cited by 6
Nanomedicine for chronic pain management: From pathophysiology to engineered drug delivery systems
Li, L., Li, T., Wang, H., Luo, L., Cheng, Y., Yang, L., Huang, S., Zhang, X., He, J., Guo, J. J., et al. (2025) · Materials Today Bio · doi:10.1016/j.mtbio.2025.101976 · Cited by 10
Bone metastases in NSCLC: Modern paradigms in management and supportive care
Minuti, G., Pasqualini, G., Avancini, A., Giaj‐Levra, N., Colonese, F., Federico, A., Fozza, A., Montrone, M., Olmetto, E., Pastorello, E., et al. (2025) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2025.103051 · Cited by 5
“Mnemonic devices can also be used to systematically remember the key questions to ask about pain (e.g., SOCRATES: site, onset, character, radiation, associated factors, timing, exacerbating/relieving factors, and severity) [71].”
LLM-driven collaborative framework for knowledge-enhanced cancer pain assessment and management
Liu, H., Hu, Y., Li, D., Shi, B., Niu, Y., Zhang, X., Zheng, G., Li, C., Wang, L., & Bao, Y. (2026) · npj Digital Medicine · doi:10.1038/s41746-026-02362-6 · Cited by 8
Aparna, S., Gopichandran, L., Garg, R. K., & Sinha, A. P. (2021) · Journal of Pain & Palliative Care Pharmacotherapy · doi:10.1080/15360288.2021.1915442 · Cited by 4
Role of Interventional Techniques in the Management of Cancer Pain
Sharma, A., Thakur, N., Thakur, A., & Bhardwaj, N. (2023) · Asian Pacific Journal of Cancer Care · doi:10.31557/apjcc.2023.8.2.391-399 · Cited by 4
“Radiotherapy and Bisphosphonates An external beam radiotherapy is a treatment option for metastatic bone pain [54-57].”
BackgroundDonati, C. M., Galietta, E., Cellini, F., Rito, A. D., Portaluri, M. G. A., Tommaso, C. D., Santacaterina, A., Tamburella, C., Mammini, F., Franco, R. D., et al. (2024) · Cancers · doi:10.3390/cancers16071407 · Cited by 4
Gaertner, J., Boehlke, C. S., Kreye, G., Fusi‐Schmidhauser, T., Mueller, E., & Roch, C. (2024) · Supportive Care in Cancer · doi:10.1007/s00520-024-08628-7 · Cited by 4
“While the ESMO-and ASCO-guidelines do not at all mention the use of non-opioids adjunct to opioids for the treatment of moderate to severe cancer pain, the German S3-guideline and the EAPC-guideline recommend the use of non-opioids [14–16].”
MethodOliveira, J., Bem, G., & Agrelo, A. (2024) · Revista Española de Anestesiología y Reanimación · doi:10.1016/j.redar.2024.01.004 · Cited by 4
Kessoku, T., Akamatsu, T., Morioka, Y., Yokota, T., Kobayashi, M., Uchida, K., Koretaka, Y., & Nakajima, A. (2024) · Japanese Journal of Clinical Oncology · doi:10.1093/jjco/hyae135 · Cited by 4
Pain in Palliative Cancer Patients – Analysis of the German National Palliative Care Registry
Ramm, M., Chung, M., Schnabel, K., Schnabel, A., Jedamzik, J., Hesse, M., Hach, M., Radbruch, L., Mücke, M., & Conrad, R. (2024) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2024.10.030 · Cited by 11
Geum, M. J., Lee, S. W., Lee, C., Jung, M., Kim, D., Yoo, Y. C., & Choi, H. J. (2025) · JCO Oncology Practice · doi:10.1200/op-24-00650 · Cited by 5
Sarma, K., Kohns, D. J., Berri, M., Joyce, E. V., & Smith, S. R. (2021) · Frontiers in Pain Research · doi:10.3389/fpain.2021.675787 · Cited by 5
Thota, R. S., Ramanjulu, R., Ahmed, A., Jain, P. N., Bhatnagar, S., Salins, N. S., Chatterjee, A. S., & Bhattacharya, D. (2020) · Indian Journal of Palliative Care · doi:10.4103/0973-1075.285694 · Cited by 5
“[16] Bisphosphonates and RANKL antagonists are bone-specific agents [Table 2][17-22] aimed at relieving bone pain and hypercalcemia and reducing the incidence of SRE.”
BackgroundWong, A. K. Y., Hawke, J. A., Eastman, P., Buizen, L., & Le, B. H. C. (2023) · Annals of Palliative Medicine · doi:10.21037/apm-22-1296 · Cited by 5
Chen, M.-C., Yeh, T., Wu, C.-C., Wang, Y.-R., Wu, C., Chen, R.-L., & Shen, C. (2023) · PLoS ONE · doi:10.1371/journal.pone.0283520 · Cited by 4
Physicochemical Stability Study of the Morphine-Bupivacaine-Ziconotide Association
Sorrieul, J., Robert, J., Blanchet, A., Gouju, J., Bienfait, F., Jubier-Hamon, S., Dupoiron, D., & Devys, C. (2024) · Neuromodulation Technology at the Neural Interface · doi:10.1016/j.neurom.2023.11.009 · Cited by 4
Ganglion impar block in chronic cancer-related pain – A review of the current literature
Oliveira, J., Bem, G., & Agrelo, A. (2024) · Revista Española de Anestesiología y Reanimación (English Edition) · doi:10.1016/j.redare.2024.04.013 · Cited by 4
Spinal Metastases of the Vertebrae: Three Main Categories of Pain
den Brande, R. V., Billiet, C., Peeters, M., & de Kelft, E. V. (2024) · Life · doi:10.3390/life14080988 · Cited by 4
Lin, R., Song, B., Li, N., Biaoxue, R., Bai, J., Liu, Y., Wang, W., Liu, A., Luo, S., Liu, B., et al. (2024) · BMC Palliative Care · doi:10.1186/s12904-024-01554-9 · Cited by 4
“Approximately 60% of cancer patients experience transient episodes of breakthrough pain that occurs on a background of relatively well-controlled baseline pain [1, 2].”
BackgroundJia, L., Wang, K., & Chen, S. (2024) · Medicine · doi:10.1097/md.0000000000040158 · Cited by 4
“[3] While opioids have been effective in managing pain for cancer patients, concerns regarding their addictive potential and adverse effects have increased in recent years.”
BackgroundDupoiron, D., Bienfait, F., Seegers, V., Piloquet, F., Pluchon, Y., Péchard, M., Mezaïb, K., Chvetzoff, G., Diaz, J., Ahmeidi, A., et al. (2025) · Cancers · doi:10.3390/cancers17020313 · Cited by 5
Emergency palliative cancer care: anxiety and midazolam
Tranung, M., Solheim, T. S., Løhre, E. T., Thronæs, M., & Larsen, M. D. (2025) · BMC Palliative Care · doi:10.1186/s12904-025-01687-5 · Cited by 4
“Nevertheless, strong opioids represent the mainstay of treatment for moderate to severe cancer-related pain [19].”
Izuegbuna, O., Kolawole, I. K., Oguntola, S., Woods-Ali, T., Oyewale, S. O., Adindu, C., Olatoke, S. A., & Olakulehin, O. A. (2025) · Pain Management · doi:10.1080/17581869.2025.2494978 · Cited by 5
Matsuoka, H., Tagami, K., Ariyoshi, K., Oyamada, S., Kizawa, Y., Inoue, A., & Koyama, A. (2019) · Japanese Journal of Clinical Oncology · doi:10.1093/jjco/hyz002 · Cited by 4
Referral Pattern to a Tertiary Care Cancer Pain Clinic in India
Chatterjee, A. S., Nimje, G. R., & Jain, P. N. (2019) · Journal of Pain & Palliative Care Pharmacotherapy · doi:10.1080/15360288.2019.1631240 · Cited by 4
Edler-Buggy, S., Birtwistle, J. C., ElMokhallalati, Y., Kindl, K., Good, P. D., & Bennett, M. (2019) · Pain · doi:10.1097/j.pain.0000000000001755 · Cited by 5
Krause, R., Nyakabau, A. M., Gwyther, L., Luyirika, E. B. K., & Kaasa, S. (2020) · ESMO Open · doi:10.1136/esmoopen-2020-000757 · Cited by 4
Areas to Improve Quality of Life After Ovarian Tumor Surgery and Adjuvant Treatment
Dobilas, A., Moberg, L., & Borgfeldt, C. (2021) · In Vivo · doi:10.21873/invivo.12517 · Cited by 4
O’Connor, L., Hassett, A., & Sheridan, N. (2021) · HRB Open Research · doi:10.12688/hrbopenres.13367.1 · Cited by 4
Lowry, S. A. (2022) · Journal of Hospice and Palliative Nursing · doi:10.1097/njh.0000000000000828 · Cited by 4
A Delphi Study on the Management of Neuropathic Cancer Pain in Spain: The DOLNEO Study
Pérez, C., Cánovas, M. L., Carmona‐Bayonas, A., Escobar, Y., Margarit, C., Cervantes, J. F. M., Quintanar, T., Afonso, A. S., & Virizuela, J. A. (2022) · Journal of Pain Research · doi:10.2147/jpr.s365351 · Cited by 4
“Although the picture has improved and more recent guidelines on cancer pain devote a specific section to CRNP,(18,19) only the European Society of Medical Oncology includes a treatment algorithm.(18) Additionally, there is still a need for a comprehensive guide fully devoted to the management of CRNP.”
BackgroundCastro, I. D. A., Castro, N. A. D. A., Nogueira, B. R., Carvalho, N. A., & Júnior, H. S. D. F. (2022) · Revista Eletrônica Acervo Médico · doi:10.25248/reamed.e10970.2022 · Cited by 4
Kamiya, T., Imai, H., Fujita, Y., Hiruta, E., Masuno, T., Yamazaki, S., Tanaka, H., Sandoh, M., Takei, S., Arai, K., et al. (2023) · Medicina · doi:10.3390/medicina59030492 · Cited by 4
Maseri, A., Delhez, Q., Dincq, A.-S., & Lacrosse, D. (2024) · BMC Medical Education · doi:10.1186/s12909-024-05359-5 · Cited by 6
“The study targeted all clinically active anesthesiologists in Belgium, including 3023 certified anesthesiologists and 638 anesthesiology trainees, as reported by the National Institute for Health and Disability Insurance (NIHDI) [19].”
Impact of opioid analgesics on survival in cancer patients receiving immune checkpoint inhibitors
Kavgacı, G., Güven, D. C., Kaygusuz, Y., Karaca, E., Dızdar, Ö., Kılıçkap, S., Aksoy, S., Erman, M., & Yalçın, Ş. (2024) · Supportive Care in Cancer · doi:10.1007/s00520-024-08681-2 · Cited by 14
“For severe pain, adjunctive therapies such as nerve blocks, epidural analgesia, and neuro-modulation techniques can provide effective pain relief while reducing the need for opioids [22].”
BackgroundSulistio, M., Gorelik, A., Tee, H. J., Wojnar, R., Kissane, D. W., & Michael, N. G. (2024) · Supportive Care in Cancer · doi:10.1007/s00520-024-08706-w · Cited by 4
“Participants were additionally de�ned as having refractory CIBP if they a) were established on a strong baseline opioid [20]; b) had ongoing worst pain score of ≥ 4/10 at CIBP site(s) [21]; and/or c) demonstrated opioid toxicity, with severity grade of ≥ 2 on the Common Terminology Criteria for…”
BackgroundUltrasound-Guided Dorsal Penile Neurolysis for Malignant Priapism Pain Management
Carvajal, G., & Rocha‐Romero, A. (2018) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2018.10.501 · Cited by 4
Alarcón, M. L., Estevez, F., Triado, V., Segura, P. P., & Comes, G. (2019) · Open Journal of Pain Medicine · doi:10.17352/ojpm.000011 · Cited by 4
“Figure 2 shows the most widely used algorithm, modifi ed from the original published in 2009 [23,34,35].”
BackgroundMethodPatton, L., Avşar, P., Nugent, L., O’Connor, T., Patton, D., & Moore, Z. E. H. (2021) · European Journal of Oncology Nursing · doi:10.1016/j.ejon.2021.102034 · Cited by 8
Nozohouri, S., Zhang, Y., Albekairi, T. H., Vaidya, B., & Abbruscato, T. J. (2021) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.121.000831 · Cited by 4
“Along with common side effects of abuse and addiction related to opioids, long-term pain management using prescribed opioids present neurovascular complications that contribute to ischemic stroke (Voon et al. 2018; Fallon et al. 2018).”
BackgroundInterventional pain management in cancer patients
Plancarte, R., & Hernández-Porras, B. C. (2020) · Postgraduate Medicine · doi:10.1080/00325481.2020.1757953 · Cited by 4
“According to ESMO guidelines, intraspinal techniques delivered and monitored by a skilled team should be included as part of the cancer pain management strategy [12].”
Rodin, R. A., & Smith, C. B. (2023) · Journal of Clinical Oncology · doi:10.1200/jco.22.02879 · Cited by 5
Mulonda, J. K., Havenga, Y., & de Villiers, M. (2023) · SAGE Open Nursing · doi:10.1177/23779608231197008 · Cited by 9
“Pain is a multidimensional concept attributed to physiological mechanisms that cause unpleasant sensory and emotional experiences associated with actual or potential tissue damage, classified as nociceptive or neuropathic (Fallon et al., 2018; Kettyle, 2023; WHO, 2018).”
BackgroundAdministración sublingual y bucal de fármacos en situaciones de urgencia y emergencia vital
Roma, J. R., Rebollo, P. C., & Bastida, C. (2024) · Medicina Clínica · doi:10.1016/j.medcli.2024.05.008 · Cited by 3
Cilla, S., Rossi, R., Donati, C. M., Habberstad, R. H., Klepstad, P., Dall’Agata, M., Valenti, V., Kaasa, S., Medici, F., MORGANTI, A. G., et al. (2025) · Clinical Medicine Insights Oncology · doi:10.1177/11795549241297054 · Cited by 3
Lee, C., Gandotra, S., Bliss, A., Jenkins, G., Dyalram, D., Hatten, K. M., Moyer, K., Mehra, R., Molitoris, J., Ferris, M., et al. (2025) · Head and Neck · doi:10.1002/hed.70089 · Cited by 3
Role of Implantable Intrathecal Pumps in Refractory Cancer Pain: Systematic Review and Meta-Analysis
Cubillos, A., Muñoz‐Montecinos, C., Maza, F., Duhalde-Saez, K., Vera, M., Quirland, C., & González‐Browne, C. (2025) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2025.10.029 · Cited by 3
Liu, S., Li, L., Zhao, B., Jiang, M., & Tian, J. (2025) · Health and Quality of Life Outcomes · doi:10.1186/s12955-025-02446-z · Cited by 5
“Among clinical symptoms in cancer patients, pain remains one of the most difficult-to-manage [2], particularly in advanced disease stages [3].”
Yang, X., Zhang, R. Q., Wang, A., Zhang, D., Cheng, J., Zhai, B., & Guo, D. (2025) · Pharmaceutics · doi:10.3390/pharmaceutics18010006 · Cited by 6
Li, X., Jia, F., Wu, P., & Wen, Q. (2026) · Current Oncology Reports · doi:10.1007/s11912-026-01734-1 · Cited by 6
Kwok, C. Y. L., Chan, D. N. S., & So, W. K. W. (2021) · European Journal of Oncology Nursing · doi:10.1016/j.ejon.2021.101945 · Cited by 3
Huang, T., Huang, Y., Hou, M., Lu, C., Chao, T., Chiu, T., Chang, Y., Lin, S., Lin, C., Chen, Y., et al. (2022) · Asia-Pacific Journal of Clinical Oncology · doi:10.1111/ajco.13772 · Cited by 3
Restivo, L., Dudoit, É., Duffaud, F., Salas, S., & Dany, L. (2022) · Journal of Psychosocial Oncology · doi:10.1080/07347332.2022.2074337 · Cited by 3
“Eligible patients were (1) suffering from pain caused by cancer or its treatment for at least one month, (2) being treated with step II and III analgesics (WHO criteria) and (3) aged between 18 and 85 years old.”
BackgroundYang, S., Tan, W., Ma, X., Qi, L., & Wang, X. (2022) · Journal of Pain Research · doi:10.2147/jpr.s378119 · Cited by 3
Mantha, S. S. P., Suvvari, P., Kodisharapu, P. K., & Rayani, B. K. (2023) · Indian Journal of Palliative Care · doi:10.25259/ijpc_205_2022 · Cited by 3
“Guidelines from the European Society of Medical Oncology recommend medical therapy for CIBP.”
BackgroundKawana, M., Miyasato, A., Funato, M., Nagatani, K., Suzuki, N., Onoda, C., Fujimoto, H., Ohno, R., Kusakabe, A., Kiribayashi, M., et al. (2023) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b23-00331 · Cited by 3
Transdermal Opioids and the Quality of Life of the Cancer Patient: A Systematic Literature Review
Reis, P. S., Kraychete, D. C., Pedreira, E. D. M., Barreto, E. S. R., Júnior, C. R. A., Alencar, V. B., Souza, A. K. D. N., Lins-Kusterer, L., & Azi, L. M. T. D. A. (2024) · Annals of Pharmacotherapy · doi:10.1177/10600280241247363 · Cited by 3
“…the analgesic effect of the transdermal fentanyl (TTS-fentanyl) 25 µg/h or paracetamol and codeine (P/C) 500 mg/day associated with radiotherapy in patients with painful bone metastasis: (lung [8]; prostate [7]; breast [4]; unknown [1]; stomach/gallbladder [3]; kidney [1]; multiple myeloma [2]).”
Myofascial pain syndrome in patients with cancer: a narrative review
Kawasaki, N., Ishiki, H., Arakawa, S., Satomi, E., Matsuoka, H., & Hasuo, H. (2024) · BMJ Supportive & Palliative Care · doi:10.1136/spcare-2024-005064 · Cited by 3
Carbonara, L., Casale, G., Marinis, M. G. D., Bosetti, C., Valle, A., Carinci, P., D'andrea, M. R., & Corli, O. (2024) · Pain Practice · doi:10.1111/papr.13418 · Cited by 3
AGREE II Evaluation of Clinical Practice Guidelines on Generalized Cancer Pain Management
Rizvi, F., Rizvi, A., Chorath, K. T., Suresh, N. V., Ng, J. J., Harris, J., Lakshmipathy, D. R., Barrette, L., & Rajasekaran, K. (2024) · Pain Management Nursing · doi:10.1016/j.pmn.2024.09.006 · Cited by 3
Breakthrough cancer pain management: mixed-methods study of health care professionals
Crawford, G. B., Lakhani, A., Palmer, L. J., Sebalj, M., & Rolan, P. E. (2024) · BMJ Supportive & Palliative Care · doi:10.1136/spcare-2024-004951 · Cited by 3
Sumimoto, T., Tanaka, R., Murakami, Y., Tatsuta, R., & Itoh, H. (2024) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.16377 · Cited by 3
“7 – 9 Although opioids produce analgesic effects by acting on opioid receptors in the central nervous system and periphery, 10 there is high interindividual variability in response caused by cancer progression and drug – drug interactions, and worsening pain control leads to further deterioration…”
Zayed, S., Lang, P., Read, N. E., Correa, R. J. M., Mutsaers, A., Goodman, C. D., D’Angelo, K., Kieraszewicz, K., Vanwynsberghe, D., Kingsbury-Paul, A., et al. (2025) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2025.110831 · Cited by 3
“Presently, opioid therapy remains central in managing RIM pain [1,7 – 9].”
Empowering people affected by penile cancer: towards a model for supportive self-management
Paterson, C. C., Earle, W., Homewood, D., Chee, J. B. L., Yao, H. H., Sengupta, S., Agbejule, O. A., Knowles, R., Ee, C., Niyonsenga, T., et al. (2025) · International Journal of Impotence Research · doi:10.1038/s41443-025-01042-5 · Cited by 4
“Mindfulness-based stress reduction (MBSR) and pain management techniques, such as guided imagery and progressive muscle relaxation [47] Offer”
Tang, J., Ding, F., Yu, M., & Cai, X. (2025) · Medicine · doi:10.1097/md.0000000000042433 · Cited by 3
“13–17] The subcutaneous dosage of hydromorphone every 3 mg is equivalent to 25 µg/h (4.125 mg) fentanyl transdermal patch, so it was necessary to apply fentanyl transdermal patch for about 5.5 patch/72 h, when opioid was used in rotation, the dose should be reduced by 10% to 20%, so we actually…”
InfluentialMwijage, J., Kyejo, W., Rubagumya, D., Kombo, T., Mathew, B., Hooda, F., Makakala, M. C., Pallangyo, E., & Chuwa, H. (2025) · BMC Cancer · doi:10.1186/s12885-025-14385-5 · Cited by 3
“Cancer is a significant global public health concern, currently recognized as a cause of mortality worldwide [1, 2].”
Froicu, E.-M., Onicescu, O.-M., Creangă-Murariu, I., Dascalu, C., Gafton, B., Afrăsânie, V.-A., Alexa‐Stratulat, T., Marinca, M. V., Pușcașu, D.-M., Miron, L., et al. (2025) · Medicina · doi:10.3390/medicina61101741 · Cited by 4
“Gabapentin and Pregabalin efficacy in the cancer-related neuropathic pain have been demonstrated in pivotal randomized trials, included as standard of care in oncology guidelines [28].”
Unmet psychosocial care needs of the oncology patients in a South African rural setting
Ramutumbu, N. J., Ramathuba, D. U., & Maputle, M. S. (2020) · Journal of Psychology in Africa · doi:10.1080/14330237.2020.1712804 · Cited by 3
Usefulness of Imaging for Intrathecal Drug Delivery Systems: An update
Dupoiron, D., Douillard, T., & Carvajal, G. (2020) · Medical Research Archives · doi:10.18103/mra.v8i7.2175 · Cited by 3
Procedural pain in patients with cancer: a Delphi expert management consensus
Estévez, F. V., Alarcón, M. D. L., Beato, C., Sanz-Yagüe, A., Porta-Sales, J., & López, R. M. M. (2021) · BMJ Supportive & Palliative Care · doi:10.1136/bmjspcare-2020-002668 · Cited by 3
The Practice of Pain Assessment and Management in a Tertiary Oncology Center
Almouaalamy, N. A., Alharbi, Z., Aldosari, F. M., Saif, S. A., Alsulimani, E. F., Aldawsari, M. K., & Alrahimi, J. S. (2021) · Cureus · doi:10.7759/cureus.18837 · Cited by 3
“Although current WHO guidelines and the classic analgesics ladder recommend the use of paracetamol in mild-to-moderate pain, patients with higher intensities of pain who are already being treated with a potent opioid may be less likely to gain any additional benefit [16,20,22-23].”
Opioid Use at End-Of-Life Among Nova Scotia Patients With Cancer
Minard, L. V., Fisher, J. E., Broadfield, L., WALSH, G. W., & SKETRIS, I. S. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.836864 · Cited by 3
The use of opioid analgesics in palliative care in Ukraine: Changes in legislation and availability
Shunkina, S., & Chukhray, I. (2022) · Palliative Medicine in Practice · doi:10.5603/pmpi.2022.0004 · Cited by 3
Managing a malignant wound in palliative care
White, D., & Kondasinghe, J. S. (2022) · Wound Practice and Research · doi:10.33235/wpr.30.3.150-157 · Cited by 10
Identifying risk factors for opioid-induced neurotoxicity in cancer patients receiving oxycodone
Omoto, T., Asaka, J., Nihei, S., & Kudo, K. (2023) · Supportive Care in Cancer · doi:10.1007/s00520-023-07676-9 · Cited by 5
Importância do manejo adequado da dor para pacientes em cuidados paliativos
Viana, V. V. P., Cabral, M. E. G., Oliveira, H. D., Rocha, R. V. S., dos Reis, J. F., do Carmo, D. M., Azevedo, P. H. L. D., Lopes, N. V. O., Carvalho, G. D. O., & Braga, V. G. R. (2023) · Brazilian Journal of Health Review · doi:10.34119/bjhrv6n3-190 · Cited by 3
High doses of opioids usage for amyotrophic lateral sclerosis patients with non-invasive ventilation
Morishima, R., Shimizu, T., Kimura, H., Bokuda, K., Saotome, T., Nakayama, Y., & Takahashi, K. (2023) · Acta Neurologica Belgica · doi:10.1007/s13760-023-02344-5 · Cited by 3
“Although there may, of course, be factors such as inadequate duration of treatment [18, 19], care-provider’s unfa-miliarity with opioid adjustment [20, 21], and difficulty in deriving spontaneous CO 2 narcosis with adequate NIV con-trol, these patients may essentially have difficulty controlling…”
Hulskotte, L. M. G., Töpfer, W., Reyners, A. K. L., Taxis, K., & Jansman, F. G. A. (2024) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-023-03612-2 · Cited by 3
“Adequate pain management is crucial in order to maintain a good quality of life [2, 3].”
BackgroundMaemoto, H., Kushi, K., Owan, I., Ariga, T., Heianna, J., & Nishie, A. (2024) · Current Oncology · doi:10.3390/curroncol31040133 · Cited by 3
Acupuncture in cancer care: a narrative review
Tsai, A. W. W., D’Alessandro, E. G., Brandão, S. A. D. S. M., Guerreiro, J. B., Bassetto, R. M., Bandeira, J. S., Pai, M. Y. B., Höhl, A., da Silva, A. V., & Sant’Anna, F. M. (2024) · Revista da Associação Médica Brasileira · doi:10.1590/1806-9282.2024s101 · Cited by 4
“Clinical studies highlight the heterogeneous nature of cancer pain, with mixed pain being considered the most common 17 .”
BackgroundXia, W., Ding, J., Yan, Y., Chen, F., Yan, M., & Xu, X. (2024) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2024.105086 · Cited by 8
Chiang, Y., Lien, C.-T., Su, W.-H., Yen, T.-Y., Chen, Y.-J., Lai, Y., Lim, K., Dai, K.-Y., Chung, H.-P., Hung, C., et al. (2024) · BMC Palliative Care · doi:10.1186/s12904-024-01483-7 · Cited by 4
“Unlike persistent background pain that is stable and manageable with long-acting opioid products, most BTcP is an unpredictable exacerbation of severe pain characterized by short duration and rapid onset [2].”
BackgroundBossi, P., Pietrzyńska, T., Ferrí, C. M., Mansilla, I., Tellone, V., Fioravanti, S., Loreto, G. D., & Comandini, A. (2024) · Frontiers in Pain Research · doi:10.3389/fpain.2024.1388837 · Cited by 3
Treatment of chronic pain in oncology: cooperation between the oncologist and psychooncologist
Pysz-Waberski, D., Bulska, W., & Wachuła, E. (2019) · Oncology in Clinical Practice · doi:10.5603/ocp.2019.0027 · Cited by 3
“Acute pain syndrome may be a complication after puncture, biopsy, endoscopy, angiography, and other diagnostic interventions [10].”
BackgroundMethodInfluentialSerotonin syndrome in advanced cancer patient treated with tramadol and antidepressants
Picco, G., Masłowska, A., Robert, A., & Ríos, R. (2019) · Palliative Medicine in Practice · doi:10.5603/pmpi.2019.0020 · Cited by 3
“Given these data on the doubtful efficacy of tramadol in treatment of oncological pain, many authors have proposed the abolition of the second step of the WHO analgesic ladder, in favour of the early use of morphine in low doses [7].”
BackgroundClark, K., Byrne, P., Hunt, J., Brown, L., Rowett, D. S., Watts, G. J., Lovell, M. R., & Currow, D. C. (2020) · Journal of Palliative Medicine · doi:10.1089/jpm.2019.0226 · Cited by 3
Knowledge of bladder cancer in the French population: results of the EDIFICE 6 survey
Morgan Rouprêt, A., Morère, J., Touboul, C., Lhomel, C., Couraud, S., & Rouge, T. D. L. M. (2020) · European Journal of Cancer Care · doi:10.1111/ecc.13392 · Cited by 3
Pain Standards for Accredited Healthcare Organizations (ACDON Project): A Mixed Methods Study
Pérez, C., Martín-Delgado, J., Sebastián, M. V., Ibor, P. J., Guilabert, M., Gomez, J., Beato, C., Sánchez-Jiménez, J., Velázquez, I., Espinós, C. C., et al. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11020102 · Cited by 4
Radiation Therapy Pain Management: Prevalence of Symptoms and Effectiveness of Treatment Options
Lamba, N., Mahal, B. A. V., Martinez, R., Leland, P., & Shih, H. A. (2019) · Clinical journal of oncology nursing · doi:10.1188/19.cjon.514-521 · Cited by 3
Corli, O., Porcu, L., Santucci, C., & Bosetti, C. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9020502 · Cited by 3
Patient perspectives on supportive care in cancer: Results of the Calista 2 study
Simon, H., Ganem, G., Touboul, C., Lhomel, C., & Morère, J. (2020) · European Journal of Cancer Care · doi:10.1111/ecc.13299 · Cited by 4
Gastrointestinal dysmotility in a patient with advanced lung cancer: paraneoplastic or drug-induced?
Dias, R. F., Diniz, M. M. L., Santos, B. C., & Junior, V. A. N. (2021) · BMJ Case Reports · doi:10.1136/bcr-2020-237835 · Cited by 3
Евгеньевич, Г. В., & Анисимов, М. А. (2022) · MD-Onco · doi:10.17650/2782-3202-2022-2-1-33-38 · Cited by 3
Fallon, M., & Ripamonti, C. I. (2018) · Annals of Oncology · doi:10.1093/annonc/mdy328 · Cited by 3
Self-citationSaito, T., Nakamura, N., Murotani, K., Shikama, N., Takahashi, T., Yorozu, A., Heianna, J., Kubota, H., Tomitaka, E., Toya, R., et al. (2020) · Advances in Radiation Oncology · doi:10.1016/j.adro.2020.09.013 · Cited by 3
“Radiation therapy is an effective treatment option for tumor-related cancer pain.(1,2) Previous studies have demonstrated that radiation therapy not only reduces bone pain but also improves the interference of pain in the patient’s daily life.”
BackgroundCancer pain is over! (If you want it)
Lemaire, A., & Rodríguez, J. E. (2022) · Supportive Care in Cancer · doi:10.1007/s00520-022-06894-x · Cited by 3
Metadata
- Authors
- Fallon, M., Giusti, R., Aielli, F., Hoskin, P., Rolke, R., Sharma, M., & Ripamonti, C. I.
- Affiliations
- Edinburgh Cancer Research (GB)
- Azienda Ospedaliera Sant'Andrea (IT)
- University of L'Aquila (IT)
- Mount Vernon Cancer Centre (GB)
- RWTH Aachen University (DE)
- Walton Centre (GB)
- Fondazione IRCCS Istituto Nazionale dei Tumori (IT)
- Venue
- Annals of Oncology
- Publisher
- Elsevier BV
- Published
- 2018-10
- Volume
- 29
- Issue
- Suppl 4
- Pages
- iv166-iv191
- ISSN
- 0923-7534 (ISSN-L)
- OpenAlex
- W2834719472
- Cited by
- 954
- References
- 184
- Citations by year
- 2026: 136 · 2025: 140 · 2024: 143 · 2023: 123 · 2022: 129 · 2021: 126 · 2020: 88 · 2019: 61 · 2018: 6
- FWCI
- 103.07
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc-nd
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 463 d)
- Locations
- Annals of Oncology (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Research Explorer (The University of Manchester) (publishedVersion, other-oa)
- RWTH Publications (RWTH Aachen) (submittedVersion)
- INFM-OAR (INFN Catania) (submittedVersion, other-oa)
- Funders
- Marie Curie (MCCC-RP-12-A14197, MCCC-RP-15-A18862, MCCC-RP-15-A19005)
- Topics
- Health Sciences › Medicine › Anesthesiology and Pain Medicine › Pain Management and Opioid Use
- Health Sciences › Medicine › Anesthesiology and Pain Medicine › Anesthesia and Pain Management
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Pediatric Pain Management Techniques
- Keywords
- cancer pain, pain management, advanced cancer, metastatic cancer, terminal cancer, pain prevalence, palliative care, analgesia
- MeSH terms
- Cancer Pain, Cancer Survivors, Pain, Procedural, Procedural Pain, Adult, Analgesics, Opioid, Antineoplastic Combined Chemotherapy Protocols, Europe, Humans, Medical Oncology, Neoplasm Staging, Neoplasms, Pain Measurement, Societies, Medical, Terminal Care, Prevalence, Treatment Outcome, Breakthrough Pain, Pain Management
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.